The Figure repeats the therapy recommendations from the ACCF/AHA/ESC* Guidelines[91][92] for the management of patients with AFib, but highlights that the current European (ESC) guidelines [93] are slightly more aggressive than the American, in that they recommend for replacing antiplatelet therapy (with aspirin) with anticoagulant therapy most patients with a CHA2DS2-VASc score of 1 or more.

 Reiffel JA. Am J Med 2013; 126: 00-00.

[*Abbrevs: ACCF, American College of Cardiology Foundation; AHA, American Heart Association; ESC, European Society of Cardiology]